Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px
Document › Details

Wilex AG. (7/15/14). "Press Release: Wilex Publishes Half-yearly Financial Report 2014". Munich.

Organisations Organisation Wilex AG
  Today Heidelberg Pharma AG (FSE: WL6)
  Group Heidelberg Pharma (Group)
  Organisation 2 UCB Pharma S.A.
  Group UCB (Group)
Products Product Redectane®
  Product 2 Mesupron®
  Index term 2 IBA (BE)–Wilex: CA9-SCAN, 200806–201404 license excl ww marketing + distrib + sales of Redectane® by IBA TERMINATED 4/14
Persons Person Schmidt-Brand, Jan (Wilex 201404– CEO before CFO + Heidelberg Pharma 200109– CEO + CFO)
  Person 2 Arnold, Katja (MC Services 201309 CIRO Executive Director before Wilex AG + CAT Consultants)
     


   
Record changed: 2017-04-02

Advertisement

Picture [iito] – Putting Information into Context 600x102px

More documents for Heidelberg Pharma (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px




» top